ODI Pharma AB (XSAT:ODI) Change In Receivables : kr-9.70 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is ODI Pharma AB Change In Receivables?

ODI Pharma AB's change in receivables for the quarter that ended in Mar. 2024 was kr-11.43 Mil. It means ODI Pharma AB's Accounts Receivable increased by kr11.43 Mil from Dec. 2023 to Mar. 2024 .

ODI Pharma AB's change in receivables for the fiscal year that ended in Jun. 2023 was kr0.33 Mil. It means ODI Pharma AB's Accounts Receivable declined by kr0.33 Mil from Jun. 2022 to Jun. 2023 .

ODI Pharma AB's Accounts Receivable for the quarter that ended in Mar. 2024 was kr7.38 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. ODI Pharma AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 48.61.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. ODI Pharma AB's liquidation value for the three months ended in Mar. 2024 was kr-0.33 Mil.

ODI Pharma AB Change In Receivables Historical Data

The historical data trend for ODI Pharma AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ODI Pharma AB Change In Receivables Chart

ODI Pharma AB Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Receivables

-0.04

-0.29

-0.67

-0.35

0.33

ODI Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															0.28	0.93	0.20	0.61	-11.43

ODI Pharma AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.70 Mil.

ODI Pharma AB (XSAT:ODI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

ODI Pharma AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	7.382	/	13.857	*	91
=	48.61

2. In Ben Graham's calculation of liquidation value, ODI Pharma AB's accounts receivable are only considered to be worth 75% of book value:

ODI Pharma AB's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	5.929	-	11.97	+	0.75 * 7.382	+	0.5 * 0.349
=	-0.33

ODI Pharma AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of ODI Pharma AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

ODI Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ODI Pharma AB (XSAT:ODI) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostermalmstorg 1, Stockholm, SWE, 114 42

Website

https://www.odipharma.com

ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.

ODI Pharma AB Headlines

No Headlines